Chengdu, China

Yan Feng

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 14.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

As a website focusing on innovations and inventions, I will gladly assist you with the article about the inventor Yan Feng.

Title: Unveiling the Innovations of Yan Feng, a Pioneer in Pharmaceutical Discoveries

Introduction: Yan Feng, a brilliant inventor based in Chengdu, China, has left an indelible mark in the field of pharmaceuticals with his cutting-edge research and groundbreaking discoveries.

Latest Patents: Yan Feng has garnered recognition for his two latest patents, focusing on the development of Azetidine derivatives as potent Janus kinase (JAK) inhibitors. These derivatives exhibit promising potential in the treatment of various JAK-related diseases, including inflammatory conditions, autoimmune disorders, and cancer.

Career Highlights: Yan Feng is an esteemed member of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., where he continues to drive innovation and spearhead advancements in drug development. His dedication to research and passion for creating impactful solutions have solidified his position as a trailblazer in the industry.

Collaborations: Throughout his career, Yan Feng has collaborated closely with accomplished professionals like Yinong Xie and Zejin You, leveraging their collective expertise to push the boundaries of pharmaceutical science. This collaborative spirit has led to synergistic partnerships that have propelled his inventions to new heights of success.

Conclusion: In conclusion, Yan Feng's contributions to the field of pharmaceuticals stand as a testament to his ingenuity and unwavering commitment to excellence. His innovative patents and collaborations underscore his status as a visionary inventor shaping the landscape of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…